Login
$ATTO
$15.00 +$1.12 (8.07%) Close

$ATTO SEC Filings

Filed On Filing
08 Oct 2026 Form 4/A: Chan Steven, Chief Financial Officer

Granted 140,000 Stock Option (Right to Buy)

08 Oct 2026 Form 3/A: Chan Steven, Chief Financial Officer
08 Oct 2026 Form 4/A: Fu Tao, Director

Granted 538,300 Stock Option (Right to Buy)

08 Oct 2026 Form 3/A: Fu Tao, Director

Holds 87,843 shares of Common Stock

02 Sep 2026 10-Q
02 Sep 2026 8-K: Results of Operations and Financial Condition
28 Aug 2026 Form 4/A: Walsh Colin, Director

Bought 85,000 shares ($1.79M) · Sold 105,807 shares ($2.25M) · Acquired 105,807 Equity Swap (Open Market Purchase) ($2.25M) · 2 more

28 Aug 2026 144
28 Aug 2026 Form 4/A: Goldman Sachs Group Inc, Former 10% Owner and 7 others

Bought 85,000 shares ($1.79M) · Sold 105,807 shares ($2.25M) · Acquired 105,807 Equity Swap (Open Market Purchase) ($2.25M) · 2 more

13 Aug 2026 Form 4: Walsh Colin, Director

Bought 85,000 shares ($1.79M) · Sold 105,807 shares ($2.25M) · Received 2,435,632 shares by conversion · 1 more

13 Aug 2026 Form 4: Goldman Sachs Group Inc, Former 10% Owner and 7 others

Bought 85,000 shares ($1.79M) · Sold 105,807 shares ($2.25M) · Received 2,435,632 shares by conversion · 1 more

12 Aug 2026 SCHEDULE 13G
11 Aug 2026 SCHEDULE 13D
10 Aug 2026 Form 4: Deep Track Biotechnology Master Fund, Ltd., 10% owner and 2 others

Received 1,957,138 shares by conversion

10 Aug 2026 Form 4: venBio Global Strategic Fund IV, L.p., 10% owner

Received 3,799,015 shares by conversion · Bought 382,352 shares ($6.5M)

07 Aug 2026 Form 4: Redmile Group, Llc, 10% owner and 2 others

Received 782,854 shares by conversion · Bought 600,000 shares ($10.2M)

07 Aug 2026 Form 4: Sanofi, 10% owner

Received 782,855 shares by conversion · Bought 300,000 shares ($5.1M)

06 Aug 2026 Form 4: Frazier Life Sciences XI, L.p., 10% owner and 2 others

Received 5,490,629 shares by conversion · Bought 588,235 shares ($10M)

06 Aug 2026 Form 4: You Angie, Director

Granted 27,000 Stock Option (Right to Buy)

06 Aug 2026 Form 4: Gold Mitchell, Director

Granted 27,000 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support